Table 3.
Outcome Type | Trials, n | (%) | aOutcome measurements, n | (%) |
---|---|---|---|---|
Patient | ||||
Symptom score | 13 | (25) | 14 | (9) |
Adverse events | 8 | (15) | 15 | (10) |
Function | 8 | (15) | 11 | (7) |
Quality of life | 5 | (9) | 17 | (11) |
Mortality | 4 | (8) | 4 | (3) |
Health perception | 2 | (4) | 5 | (3) |
Psychological morbidity | 2 | (4) | 6 | (4) |
Absenteeism | 1 | (2) | 1 | (1) |
Clinical status | 9 | (17) | 9 | (6) |
Residual disease rate | 7 | (13) | 7 | (5) |
Recurrent disease rate | 6 | (11) | 7 | (5) |
Patient outcome total | 53 | (54) | 96 | (64) |
Process | ||||
Therapeutic yield | 17 | (45) | 20 | (13) |
Timing of care | 8 | (21) | 8 | (5) |
Cost | 7 | (18) | 7 | (5) |
Appropriateness of treatment decision | 5 | (13) | 6 | (4) |
Diagnostic yield | 4 | (11) | 5 | (3) |
Process outcome total | 38 | (39) | 46 | (31) |
Composite outcome | ||||
Adverse patient and process event rate | 7 | (7) | 7 | (5) |
Primary outcome not defined | 6 | (6) | 0 | (0) |
Total | 103 | (100) | 149 | (100) |
aMany trials included more than one primary outcome